DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Equagesic (Meprobamate / Aspirin) - Summary

 
 



EQUAGESIC SUMMARY

General

Each tablet of Equagesic, for oral administration, contains 200 mg meprobamate and 325 mg aspirin.

As an adjunct in the short-term treatment of pain accompanied by tension and/or anxiety in patients with musculoskeletal disease. Clinical trials have demonstrated that in these situations relief of pain is somewhat greater than with aspirin alone.  Equagesic is not intended for use longer than 10 days.


See all Equagesic indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Equagesic (Meprobamate / Aspirin)

Prolotherapy May Help Ease Knee Joint Pain
Source: Medscape Anesthesiology Headlines [2017.03.23]
Prolotherapy, an alternative medicine approach to joint pain that typically uses injections of sugar or sodium, may be worth trying for knee osteoarthritis after traditional approaches fail, a recent review suggests.
Reuters Health Information

Outpatient Pain Service Cuts Costs in 'High Utilizers'
Source: Medscape Anesthesiology Headlines [2017.03.23]
An intensive outpatient pain management program slashed about 45% in costs incurred annually by high utilizers of the healthcare system, researchers report.
Medscape Medical News

Simulation Promising Pain Medicine Teaching Tool
Source: Medscape Anesthesiology Headlines [2017.03.23]
New research shows the value of immersion training and using a simulated patient encounter for pain medicine-related education.
Medscape Medical News

'Spray painting' shows promise as minimally invasive way to patch up the heart
Source: Cardiovascular / Cardiology News From Medical News Today [2017.03.22]
Spray painting biomaterials shows promise as a minimally invasive way to create a regenerative patch on the heart to repair tissue after heart attack.

A single glucocorticoid injection provides only short-term relief from chronic low back pain
Source: Pain / Anesthetics News From Medical News Today [2017.03.22]
A single intradiscal glucocorticoid injection reduces low back pain associated with active discopathy at 1 month for patients in which first-line conservative treatments had failed.

more news >>


Page last updated: 2017-03-23

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017